CHEMICAL ENTITY

DOSAGE FORM

NOTE

1.1. General anaesthetics and oxygen  

1.1.1 Inhalational medicines  

Isoflurane  

Inhalation

Nitrous oxide

Inhalation

1.1.2 Injectable medicines  

Ketamine

Injection

Propofol*

Injection

Thiopental may be used as an alternative depending on availability and cost

1.2 Local anaesthetics  

Bupivacain

Injection

Lignocaine

Injection

Lidocaine + epinephrine

Injection

Complementary list

Ephedrine

Injection

1.3 Preoperative medications and sedation for short-term procedures

Atropine

Injection

Midazolam

Injection Oral

Morphine

Injection

1.4 Medical Gases  

Oxygen*

Inhalation

* No more than 30% oxygen should be used to initiate resuscitation of neonates less than or equal to 32 weeks of gestation.

CHEMICAL ENTITY

DOSAGE FORM

NOTE

2.1 Non-opioids and non-steroidal anti-inflammatory medicines    

Acetylsalicylic acid  

Oral

Ibuprofen [a]

Oral

[a] > 3 months

Paracetamol *

Oral

Suppository

* Not recommended for anti-inflammatory use due to lack of proven benefit to that effect  

2.2 Opioid analgesics  

Fentanyl *

Transdermal patch 

* For the management of cancer pain

Morphine

Injection

Oral

Complementary lists  

Oxycodone

Oral  

*Alternative to morphine for patient with severe morphine intolerance  

Tramadol [a]

Injection

Oral

[a] > 12 years

Dihydrocodeine tartrate

Oral

2.3 Medicines for other common symptoms in palliative care

Amitriptyline

Oral

Dexamethasone

Injection

Oral

Diazepam

Injection

Oral

Rectal solution

Fluoxetine [a]

Oral

[a] > 8 years old

Haloperidol

Injection

Oral

Hyoscine butylbromide

Injection

Hyoscine hydrobromide

Injection

Lactulose

Oral

Loperamide

Oral

Lorazepam

Oral

Metoclopramide [a]

Injection

Oral

[a] Not for neonates

Midazolam

Injection

Oral

Ondansetron [a]

Injection

Oral

[a] > 1 month

Complementary list

Gabapentin

Oral

CHEMICAL ENTITY

DOSAGE FORM

NOTE

Chlorpheniramine [a]  

Injection

Oral

[a] > 2 years

Dexamethasone

Injection

Epinephrine (adrenaline)

Injection

Hydrocortisone

Injection  

Loratadine

Oral

Prednisolone

Oral

CHEMICAL ENTITY

DOSAGE FORM

NOTE

4.1 Non-specific  

Charcoal, activated

Oral

4.2 Specific

Acetylcysteine

Injection  

Atropine

Injection

Calcium gluconate

Injection

Flumazenil

Injection

Methylthioninium chloride (methylene blue)

Injection

Naloxone

Injection

Penicillamine

Oral

Pralidoxime

Injection

Sodium nitrite

Injection

Sodium thiosulfate

Injection

Complementary list

Deferoxamine

Injection

Dimercaprol

Injection

CHEMICAL ENTITY

DOSAGE FORM

NOTE

Carbamazepine  

Oral

 Diazepam  

Injection Rectal solution     

Lamotrigine*  

Oral  

* As adjunctive therapy for treatment-resistant partial or generalised seizures  

 Magnesium sulphate*

Injection

* For use in eclampsia or severe pre-eclampsia and not for other convulsant disorders  

Phenobarbital  

Injection

Oral

Phenytoin  

Injection

Oral

Valproic acid

(sodium valproate)  

Oral

Complementary list

Valproic acid

(sodium valproate)  

Injection  

CHEMICAL ENTITY

DOSAGE FORM

NOTE

6.1 Anthelmintics      

6.1.1 Intestinal anthelmintics  

Albendazole

Oral

6.1.2 Antifilarials  

Diethylcarbamazine

Oral

6.2 Anti-bacterials  

6.2.1 Antibiotics  

Antibiotics are divided into three different categories namely ACCESS, WATCH and RESERVE groups to facilitate the development of tools for antibiotic stewardship at local and national levels and to reduce antimicrobial resistance. These groups were made to emphasize the importance of their proper use.

ACCESS GROUP ANTIBIOTICS :

• Antibiotics that have activity against a wide range of commonly encountered susceptible pathogens

• Antibiotics that also show lower resistance potential than antibiotics in the other groups

These are essential antibiotics that should be widely available in Malaysian health facilities.

WATCH GROUP ANTIBIOTICS:

• Antibiotics with higher resistance potential when compared with the Access group which includes antibiotics such as third generation cephalosporins, fluoroquinolones and carbapenems

• These antibiotics should be prescribed only for specific indications

These medicines should be prioritised as key targets of stewardship programs and monitoring.

RESERVE GROUP ANTIBIOTICS

• Antibiotic classes that should be reserved for treatment of confirmed or suspected infections due to multi-drug-resistant organisms

These antibiotics should be treated as “last resort” options  

6.2.1.1 Access group antibiotics  

Amikacin

Injection  

Amoxycillin

Injection

Oral

Amoxycillin + clavulanic acid

Injection

Oral

Ampicillin  

Injection

Benzathine benzylpenicillin

Injection

Benzylpenicillin  

Injection

Cefazolin [a]  

Injection

[a] > 1 month

Cephalexin  

Oral

Cloxacillin  

Injection

Oral

Doxycycline [a]  

Oral

[a] Use in children < 8 years only for life-threatening infections when no alternative exists

Erythromycin  

Oral

Gentamicin  

Injection  

Metronidazole  

Injection

Oral

Suppository  

Nitrofurantoin  

Oral

Phenoxymethylpenicillin

Oral

Procaine benzylpenicillin*

Injection  

* Not recommended as first-line treatment for neonatal sepsis except in settings with high neonatal mortality, when given by trained health workers in cases where hospital care is not achievable.  

Sulphamethoxazole + trimethoprim  

Injection

Oral  

6.2.1.2 Watch group antibiotics  

Azithromycin  

Injection

Oral

Cefotaxime

Injection

Ceftriaxone* [a]  

Injection

*Do not administer with calcium and avoid in infants with hyperbilirubinaemia

[a] >41 weeks corrected gestational age  

Cefuroxime  

Injection

Ciprofloxacin  

Injection

Oral

Piperacillin + tazobactam

Injection

Complementary list  

Ceftazidime  

Injection

Meropenem  

Injection

[a] > 3 months  

Vancomycin  

Injection  

6.2.1.3 Reserve group antibiotics  

Complementary list  

Cefepime  

Injection  

Colistin  

Injection

Linezolid  

Injection

Oral  

Polymycin B  

Injection

6.2.2 Antileprosy medicines

Medicines used in the treatment of leprosy should never be used except in combination. Combination therapy is essential to prevent the emergence of drug resistance.  

Clofazimine  

Oral  

Dapsone  

Oral

Rifampicin  

Oral

6.2.3 Antituberculosis medicines  

Ethambutol  

Oral

Ethambutol + isoniazid + pyrazinamide + rifampicin

Oral

Isoniazid  

Oral

Isoniazid + rifampicin

Oral

Pyrazinamide

Oral

Rifampicin  

Oral

Complementary list  

Amikacin  

Injection  

Cycloserine  

Oral

Ethionamide  

Oral

Kanamycin

Injection

Streptomycin

Injection

6.3 Antifungal medicines  

Amphotericin B  

Injection

Clotrimazole  

Pessary  

Fluconazole  

Injection

Oral

Griseofulvin  

Oral

Itraconazole  

Oral

Nystatin  

Oral

Voriconazole*  

Injection

Oral  

*For treatment of chronic pulmonary aspergillosis and acute invasive aspergilosis.  

6.4 Antiviral medicines

6.4.1 Antiherpes medicines  

Acyclovir  

Injection

Oral

6.4.2 Antiretrovirals  

6.4.2.1 Nucleoside/Nucleotide reverse transcriptase inhibitors  

Lamivudine (3TC)  

Oral

Tenofovir disoproxil fumarate (TDF)  

Oral

Zidovudine (ZDV or AZT)

Injection

Oral

6.4.2.2 Non-nucleoside reverse transcriptase inhibitors  

Efavirenz (EFV or EFZ) [a]

Oral

[a] > 3 years or > 10 kg weight

Nevirapine (NVP) [a]

Oral

[a] > 6 weeks  

6.4.2.3 Protease inhibitors  

Atazanavir [a]  

Oral

[a] >25kg  

Lopinavir + ritonavir (LPV/r)  

Oral

Ritonavir  

Oral

6.4.2.4 Integrase inhibitors  

Dolutegravir [a]  

Oral

[a] ≥25kg  

Raltegravir*  

Oral

*For use in pregnant women and second-line regimens following international and national treatment guidelines.

FIXED-DOSE COMBINATIONS  

Abacavir + lamivudine

Oral

Emtricitabine + tenofovir

Oral

Lamivudine + zidovudine

Oral

Lamivudine + nevirapine + stavudine  

Oral

6.4.3 Other antivirals  

Ribavirin  

Oral

Complementary list  

Oseltamivir  

Oral  

6.4.4 Antihepatitis medicines  

6.4.4.1 Medicines for hepatitis B  

6.4.4.1.1 Nucleoside/Nucleotide reverse transcriptase inhibitors  

Entecavir  

Oral  

Tenofovir disoproxil fumarate (TDF)  

Oral  

6.4.4.2 Medicines for hepatitis C  

Ribavirin*  

Oral

* For the treatment of hepatitis C, in combination with peginterferon and/or direct acting anti-viral medicines  

Complementary list

Pegylated interferon alfa 2a  

Injection  

6.5 Antiprotozoal medicines  

6.5.1 Antiamoebic and antigiardiasis medicines  

Metronidazole  

Injection

Oral  

6.5.2 Antimalarial medicines  

6.5.2.1 For curative treatment  

Artemether + lumefantrine*  

Oral

* Not recommended in the first trimester of pregnancy or children < 5 kg.  

Artesunate*  

Injection

* To be used in combination with either amodiaquine, mefloquine or sulfadoxine + pyrimethamine.  

Artesunate + mefloquine

Oral

Chloroquine*  

Oral

* Only for the treatment of P.vivax infection.  

Doxycycline*  

Oral

* Only in combination with quinine  

Primaquine*  

Oral

* Only for use to achieve radical cure of P.vivax and P.ovale infections.  

Quinine*  

Injection

Oral  

* Only for severe malaria, and should be used in combination with doxycycline.  

Sulfadoxine + pyrimethamine  

Oral

6.5.2.2 For prophylaxis  

Doxycycline [a]

Oral

[a] > 8 years  

Mefloquine [a]  

Oral

[a] >5kg or >3 months  

6.5.3 Antipneumocystosis and anti-toxoplasmosis medicines  

Sulfamethoxazole + trimethoprim  

Oral  

Complementary list

Pentamidine  

Injection  

CHEMICAL ENTITY

DOSAGE FORM

NOTE

7.1 For treatment of an acute attack  

Ibuprofen     

Oral dosage form  

Paracetamol 

Oral dosage form  

7.2 For prophylaxis  

Propranolol  

Oral dosage form   

CHEMICAL ENTITY

DOSAGE FORM

NOTE

8.1 Immunomodulators for non-malignant disease  

Complementary list  

 Adalimumab*     

Injection  

* Etanercept, Golimumab and Infliximab are alternatives and including quality assured biosimilars  

Azathioprine  

Oral  

 Ciclosporin

Injection

Oral

8.2 Antineoplastics and supportive medicines  

8.2.1 Cytotoxic medicines  

Complementary list

Asparaginase   

Injection

Bendamustine  

Injection

Bleomycin  

Injection

Calcium folinate  

Injection

Oral

Capecitabine  

Oral

Carboplatin  

Injection

Chlorambucil  

Oral

Cisplatin  

Injection

Cyclophosphamide  

Injection

Oral

Cytarabine  

Injection

Dacarbazine  

Injection

Dactinomycin  

Injection

Daunorubicin  

Injection

Docetaxel  

Injection

Doxorubicin  

Injection

Etoposide  

Injection

Oral

Fludarabine  

Injection

Oral

Fluorouracil  

Injection

Gemcitabine  

Injection

Ifosfamide  

Injection

Irinotecan  

Injection

Mercaptopurine  

Oral

Methotrexate  

Injection

Oral

Oxaliplatin  

Injection  

Paclitaxel  

Injection  

Procarbazine  

Oral

Tioguanine  

Oral

Vinblastine  

Injection  

Vincristine  

Injection  

8.2.2 Targeted therapies  

Complementary list

All-trans retinoid acid (ATRA)

Oral

Bortezomib  

Injection  

Erlotinib*  

Oral

* Gefitinib as alternatives  

Nilotinib  

Oral

Nilotinib  

Oral

Rituximab*  

Injection

* Including quality assured biosimilars  

Trastuzumab*  

Injection

* Including quality assured biosimilars  

8.2.3 Immunomodulators  

Complementary list

Filgrastim  

Injection

* Including quality assured biosimilars

Thalidomide  

Oral

8.2.4 Hormones and antihormones  

Complementary list

Abiraterone  

Oral

Anastrozole  

Oral

Bicalutamide  

Oral

Dexamethasone  

Injection

Oral

Hydrocortisone  

Injection

Leuprorelin  

Injection

Methylprednisolone

Injection

Prednisolone  

Oral

Tamoxifen  

Oral

8.2.5 Supportive medicines    

Complementary list

Allopurinol  

Oral

Mesna  

Injection

Oral

Zoledronic acid  

Injection

CHEMICAL ENTITY

DOSAGE FORM

NOTE

Levodopa + carbidopa

Oral  

CHEMICAL ENTITY

DOSAGE FORM

NOTE

10.1 Antianaemia medicines  

Ferrous salt  

Oral

Injection 

Folic acid    

Oral  

Complementary list

Erythropoiesis-stimulating agents  

Injection  

* Including quality assured biosimilars.  

10.2 Medicines affecting coagulation  

Dabigatran   

Oral   

*Apixaban and Rivaroxaban are alternatives  

Enoxaparin  

Injection

Heparin sodium  

Injection

Phytomenadione  

Injection

Protamine sulfate  

Injection

Tranexamic acid  

Injection

Oral

Warfarin  

Oral

Complementary list

Desmopressin  

Injection  

10.3 Other medicines for haemoglobinopathies  

Complementary list

Desferrioxamine*  

Injection  

*Also known as Deferoxamine

**Deferasirox oral form may be an alternative, depending on cost and availability  

CHEMICAL ENTITY

DOSAGE FORM

NOTE

11. 1 Blood and blood components

Fresh frozen plasma

Transfusion bag  

Platelets    

Transfusion bag   

Red blood cells  

Transfusion bag

Whole blood  

Transfusion bag

11.2 Plasma-derived medicines  

11.2.1 Human immunoglobulins  

Anti-D immunoglobulin

Injection  

Anti-rabies immunoglobulin

Injection

Anti-tetanus immunoglobulin  

Injection

Complementary list

Normal immunoglobulin

Injection  

11.2.2 Blood coagulation factors    

Complementary list

Coagulation factor VIII

Injection   

Coagulation factor IX

Injection

11.3 Plasma substitutes  

Human Albumin   

Injection

Modified fluid gelatin

Injection

CHEMICAL ENTITY

DOSAGE FORM

NOTE

12.1 Antianginal medicines        

Bisoprolol*  

Oral

*Includes Metoprolol and Carvedilol as alternatives  

Glyceryl trinitrate  

Oral

Isosorbide dinitrate

Oral

Verapamil  

Oral

Complementary lists  

Glyceryl trinitrate  

Injection

Isosorbide dinitrate

Injection

12.2 Antiarrhythmic medicines  

Bisoprolol* 

Oral  

*Includes Metoprolol and Carvedilol as alternatives

Digoxin  

Injection

Oral

Epinephrine (adrenaline)

Injection

Lignocaine   

Injection

Verapamil  

Injection

Oral

Complementary list  

Amiodarone  

Injection

Oral

Norepinephrine (Noradrenaline)  

Injection

12.3 Antihypertensive medicines  

Amlodipine    

Oral

Bisoprolol* 

Oral  

*Includes Atenolol, Metoprolol and Carvedilol as alternatives

Enalapril     

Oral  

Hydralazine*

Injection

* Use only in the acute management of severe pregnancy-induced hypertension.  

Hydrochlorothiazid 

Oral

Losartan    

Oral

Labetalol  

*Oral

**Injection

* for pregnancy

**for hypertension crisis   .

Methyldopa*

Oral  

* Use only in the management of pregnancy-induced hypertension.  

12.4 Medicines used in heart failure    

Bisoprolol* 

Oral  

*Includes Metoprolol and Carvedilol as alternatives

Digoxin    

Injection

Oral  

Enalapril    

Oral

Furosemide   

Injection

Oral

Losartan    

Oral

Spironolactone  

Oral

Complementary list  

Dopamine   

Injection

12.5 Antithrombotic medicines  

12.5.1 Anti-platelet medicines  

Acetylsalicylic acid  

Oral  

Clopidogrel

Oral

12.5.2 Thrombolytic medicines    

Complementary list  

Alteplase     

Injection  

Streptokinase   

Injection

12.6 Lipid-lowering agents.  

Gemfibrozil   

Oral  

Simvastatin   

Oral

CHEMICAL ENTITY

DOSAGE FORM

NOTE

13.1 Antifungal medicines  

Miconazole  

Topical  

13.2 Anti-infective medicines  

Mupirocin  

Topical

Potassium permanganate

Miscellaneous  

Silver sulfadiazine [a]

Topical

[a] > 2 months  

Neomycin  

Topical

13.3 Anti-inflammatory and antipruritic medicines  

Betamethasone [a]  

Topical 

[a] not preferred in neonates

Calamine  

Topical

Hydrocortisone*  

Topical

*preferred in neonates  

13.4 Medicines affecting skin differentiation and proliferation  

Aqueous cream

Topical

Benzoyl peroxide  

Topical

Coal tar  

Topical

Salicylic acid  

Topical

13.5 Scabicides and pediculicides  

Benzyl benzoate [a]

Topical

[a] > 2 years  

Permethrin  

Topical

CHEMICAL ENTITY

DOSAGE FORM

NOTE

14.1 Ophthalmic medicines  

Fluorescein     

Miscellaneous  

Tropicamide    

Eye Preparation 

14.2 Radiocontrast media  

Amidotrizoate*  

Injection 

*As sodium or meglumine salt

Barium sulfate  

Oral

Iohexol  

Injection  

CHEMICAL ENTITY

DOSAGE FORM

NOTE

Acriflavin      

Topical     

Alcohol       

Topical 

Chlorhexidine  

Topical 

Povidone iodine  

Topical

CHEMICAL ENTITY

DOSAGE FORM

NOTE

Frusemide       

Injection

Oral      

Hydrochlorothiazide   

Oral

Spironolactone   

Oral 

CHEMICAL ENTITY

DOSAGE FORM

NOTE

17.1 Antiulcer medicines and Antacid  

Omeprazole  

Injection

Oral  

Ranitidine   

Injection

Oral  

Magnesium trisilicate

Oral  

17.2 Antiemetic medicines  

Metoclopramide [a]

Injection

Oral   

a] not in neonates 2

Ondansetron [a]  

Injection

Oral

[a] > 1 month  

Complementary list

Aprepitant  

Oral  

17.3 Laxatives    

Complementary list

Bisacodyl  

Oral

Suppository    

Glycerin 25% and Sodium Chloride 15% Enema

Enema  

Lactulose  

Oral

17.4 Medicines used in diarrhoea    

Oral rehydration salts

Oral  

17.5 Antispasmodic Medicines  

Hyoscine  

Injection

Oral

CHEMICAL ENTITY

DOSAGE FORM

NOTE

18.1 Adrenal hormones and synthetic substitutes  

Dexamethasone  

Injection

Oral  

Fludrocortisone     

Oral  

Hydrocortisone  

Oral  

18.2 Androgens  

Complementary list  

Testosterone  

Injection  

18.3 Estrogens  

18.4 Progestogens  

Medroxyprogesterone acetate  

Oral

18.5 Medicines for diabetes  

18.5.1 Insulins  

Insulin injection (soluble)

Injection  

Intermediate-acting insulin

Injection

18.5.2 Oral hypoglycaemic agents    

Gliclazide   

Oral  

Metformin  

Oral

18.6 Thyroid hormones and antithyroid medicines  

Carbimazole  

Oral

Levothyroxine  

Oral

Propylthiouracil  

Oral

Lugol’s solution  

Oral

CHEMICAL ENTITY

DOSAGE FORM

NOTE

19.1 Diagnostic agents  

Tuberculin, purified protein derivative (PPD)  

Injection 

19.2 Sera and immunoglobulins  

Antirabies Immunoglobulin (Human)     

Injection 

Antivenene Cobra Injection

Injection

Antivenene Pit Viper Injection  

Injection

Antivenene Serum (Sea snake) 1000 units Injection

Injection

Diphtheria antitoxin

Injection

Hemato Polyvalent Snake Antivenene Injection

Injection

Neuro Polyvalent Snake Antivenene Injection

Injection

Tetanus Immunoglobulin Human  

Injection

19.3 Vaccines  

National Immunisation Policy recommendations are determined by MOH Malaysia. Immunisation schedule is updated periodically and be accessed www.myhealth.gov.my/jadual-imunisasi/. The following list of vaccines is in accordance with immunisation schedule 2019. All vaccines should comply to MOH requirements.  

BCG vaccine

Injection

Diphtheria + tetanus vaccine

Injection

Diphtheria, Tetanus, Acellular Pertussis, Inactivated Polio Virus, Haemophilus Influenza Type B Vaccine [DTaP-IPV- Hib]

Injection  

Haemophilus influenzae type b vaccine  

Injection

Hepatitis B vaccine  

Injection

HPV vaccine  

Injection

Japanese encephalitis vaccine*  

Injection 

*Only applicable for Sarawak  

Measles vaccine  

Injection

Measles, Mumps & Rubella Vaccine (Live)  

Injection

Pneumococcal vaccine

Injection

Poliomyelitis vaccine

Injection

Tetanus vaccine   

Injection

CHEMICAL ENTITY

DOSAGE FORM

NOTE

Atracurium  

Injection  

Neostigmine  

Injection 

Suxamethonium  

Injection 

Complementary list  

Pyridostigmine  

Oral  

CHEMICAL ENTITY

DOSAGE FORM

NOTE

21.1 Anti-infective agents  

Acyclovir  

Eye Preparation  

Chloramphenicol     

Eye Preparation   

Gentamicin   

Eye Preparation   

21.2 Anti-inflammatory agents  

Prednisolone   

Eye Preparation   

21.3 Local anaesthetics  

Proparacaine  

Eye Preparation 

21.4 Miotics and antiglaucoma medicines  

Acetazolamide  

Injection

Oral  

Latanoprost  

Eye Preparation

Pilocarpine  

Eye Preparation

Timolol  

Eye Preparation

21.5 Mydriatics    

Atropine [a]   

Eye Preparation   

[a] >3 months.  

Complementary lists  

Phenylephrine   

Eye Preparation 

CHEMICAL ENTITY

DOSAGE FORM

NOTE

22.1 Contraceptives  

22.1.1 Oral hormonal contraceptive  

Ethinylestradiol + levonorgestrel  

Oral  

levonorgestrel  

Oral  

22.1.2 Injectable hormonal contraceptives  

Medroxyprogesterone acetate  

Injection

Norethisterone enanthate

Injection

22.1.3 Intrauterine devices

Copper-containing device

Intrauterine Device  

Levonorgestrel-releasing intrauterine system

Intrauterine Device  

22.1.4 Implantable contraceptive  

Etonogestrel-releasing implant  

Implant

22.2 Ovulation inducers  

Complementary list  

Clomifene  

Oral

22.3 Uterotonics  

Oxytocin  

Injection

Oxytocin + Ergometrine maleate  

Injection

22.4 Medicines administered to the mother  

Dexamethasone  

Injection

Tranexamic acid  

Injection

22.5 Medicines administered to the neonate  

*Chlorhexidine  

Topical Solution  

*Chlorhexidine 2% in 70% alcohol for umbilical cord care

Complementary list  

Surfactant  

Injection

CHEMICAL ENTITY

DOSAGE FORM

NOTE

Complementary list

Intraperitoneal dialysis solution (of appropriate composition)  

Parenteral solution  

CHEMICAL ENTITY

DOSAGE FORM

NOTE

24.1 Medicines used in psychotic disorders    

Chlorpromazine   

Oral     

Fluphenazine   

Injection  

Haloperidol    

Injection

Oral 

Risperidone  

Oral

Complementary list  

Clozapine  

Oral

24.2 Medicines used in mood disorders  

24.2.1 Medicines used in depressive disorders  

Amitriptyline 

Oral 

Fluoxetine [a]  

Oral

[a] > 8 years  

Sertraline  

Oral

24.2.2 Medicines used in bipolar disorders  

Lithium carbonate  

Oral

Valproic acid (sodium valproate)  

Oral

24.3 Medicines for anxiety disorders    

Diazepam    

Oral

Clonazepam  

Oral

24.4 Medicines used for obsessive-compulsive disorders  

Clomipramine  

Oral dosage form  

24.5 Medicines for disorders due to psychoactive substance use  

Nicotine replacement therapy (NRT)  

Oral

Patch  

Complementary list  

Methadone*  

Oral

*The medicines should only be used within an established support programme.  

CHEMICAL ENTITY

DOSAGE FORM

NOTE

25.1 Antiasthmatic and medicines for chronic obstructive pulmonary disease  

Aminophylline  

Injection     

Beclomethasone  

Inhalation  

Budesonide   

Inhalation  

Budesonide + formoterol

Inhalation

Epinephrine (adrenaline)

Injection

Ipratropium bromide

Inhalation

Prednisolone

Oral 

Salbutamol

Injection

Inhalation 

Theophylline  

Oral

25.2 Antitussives  

Diphenhydramine Hydrochloride  

Oral

25.3 Mucolytics    

Bromhexine  

Oral

CHEMICAL ENTITY

DOSAGE FORM

NOTE

26.1 Oral  

Oral rehydration salts

Oral     

Potassium chloride  

Oral

26.2 Parenteral    

Glucose  

Injection  

Glucose with sodium chloride    

Injection

Potassium chloride  

Injection

Sodium bicarbonate

Injection

Sodium chloride  

Injection  

Sodium lactate, compound solution  

Solution  

26.3 Miscellaneous    

Water for injection  

Injection

Irrigation  

CHEMICAL ENTITY

DOSAGE FORM

NOTE

Ascorbic acid     

Oral  

Calcium     

Oral 

Pyridoxine   

Oral 

Thiamine  

Oral

Complementary list  

Calcium gluconate  

Injection 

CHEMICAL ENTITY

DOSAGE FORM

NOTE

Budesonide  

Nasal spray  

Chloramphenicol  

Ear drops  

Oxymetazoline

Nasal spray/nasal drops  

a] > 6 years  

CHEMICAL ENTITY

DOSAGE FORM

NOTE

29.1 Medicines used to treat gout    

Allopurinol    

Oral dosage form

Colchicine    

Oral dosage form   

Indomethacin     

Oral dosage form

29.2 Disease-modifying agents used in rheumatoid disorders (DMARDs)  

Chloroquine  

Oral dosage form

Complementary list  

Azathioprine   

Oral dosage form 

Hydroxychloroquine

Oral dosage form

Methotrexate  

Oral dosage form

Sulfasalazine  

Oral dosage form